Ill: "The value to the cancer patients is a completely different subject that has NOTHING to do with STOCK."
This is a fundamental mistake! Ultimately, the job of the FDA is to make a
determination of whether, on the whole, given the often terrible choices facing
cancer patients, does the drug offer some relief.
If the answer is yes, then the mandate of the FDA is to approve the drug.
AND, if the drug is approved, the pps will react positively.
Yes, I'm fully aware that I invested in Ariad to make money. I just feel better about
being in a position to hope for the best for the patient. I like my hopes to be
aligned with that of patients and their families.
Market Data 
Markets 
AI
